Home Editor's Picks China’s first homegrown airliner makes international debut in Singapore

China’s first homegrown airliner makes international debut in Singapore


China’s first homegrown airliner makes international debut in Singapore By Reuters

Breaking News


Stock Markets

Published Feb 17, 2024 11:48PM ET

© Reuters. A Comac C919 flies past during an aerial flying display ahead of the Singapore Airshow at Changi Exhibition Centre in Singapore February 18, 2024. REUTERS/Edgar Su

By Lisa Barrington

SINGAPORE (Reuters) – China’s challenger to Airbus and Boeing (NYSE:BA)’s passenger jets, the narrow-body C919 manufactured by the Commercial Aircraft Corporation of China (COMAC), has made its first trip outside Chinese territory, staging a fly-by at the Singapore Airshow on Sunday.

China has invested heavily in its attempt to break the hold of the dominant two Western planemakers on the global passenger market.

China has indicated a push this year to advance the C919 and COMAC’s footprint domestically and internationally. The plane is only certified within China and the first of now four C919s began flying with China Eastern Airlines (OTC:CEAYY) last year.

With Airbus and Boeing struggling to ramp up production and meet demand for new planes, and Boeing struggling with a string of crises, the aviation industry is watching how COMAC positions itself as a viable alternative.

COMAC will invest tens of billions of yuan over the next 3-5 years to expand C919 production capacity, Chinese media reported a COMAC official saying in January.

China’s aviation authority said last month it would this year pursue European Union Aviation Safety Agency (EASA) validation for the C919, a process which began in 2018.

The C919 was one of two commercial planemakers flying their planes off Singapore’s coast alongside Airbus at a Sunday preview for Asia’s biggest air show. Boeing will not display a commercial aircraft this year.

COMAC has two passenger products: the ARJ21 regional jet and the larger C919 twin-engine narrow-body airliner with 158-192 seats, which competes with the established Airbus A320neo and Boeing 737 MAX 8 models.

The C919 made its first flight outside mainland China in December to Hong Kong. ARJ21s are in use by Indonesia’s TransNusa Air.

Many inside the industry caution that only four C919s are in service in China; the plane is only certified by Chinese regulators and the C919 relies international supply chains.

However the aviation industry-wide supply crunch, which is testing an expected full return and then growth of civil capacity in Asia, is garnering COMAC more attention.

“We have also seen a growing trend where clients are including the C919 option in their fleet evaluation,” said Adam Cowburn of Alton Aviation Consultancy.

Two C919s were delivered in 2023. Aviation consultancy IBA forecasts 7-10 C919s could be delivered in 2024.

“With Airbus and Boeing narrowbodies in the A320neo and 737 MAX families sold out for most of this decade, the C919 has a strong opportunity to gain market share, particularly in its domestic market,” said Mike Yeomans of aviation consultancy IBA.

“The immediate challenges for COMAC are around production to meet local demand and certification to penetrate international markets,” Yeomans added.

China’s first homegrown airliner makes international debut in Singapore

Our Apps

Terms And Conditions
Privacy Policy
Risk Warning
Do not sell my personal information

© 2007-2024 Fusion Media Limited. All Rights Reserved.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Related News